| UCSF Magazine

How Big Tobacco Helped Shape the Design of Ultra-Processed Foods

A study looked at how ultraprocessed foods (UPFs), like Lunchables, are designed—and why they may lead to overeating and weight gain. Using internal company documents, the study showed that Lunchables were influenced by strategies from the tobacco industry, specifically Philip Morris, which once owned Kraft.

A Stroke Left 17-Year-Old Andrew Hunched on the Floor in Pain

Two decades ago, children with stroke were falling into this gap between stroke providers who didn’t treat children and child neurologists who were uncomfortable with stroke. Today, UCSF is at the forefront of pediatric stroke care and research.

Global Rules Could Cut Costs and Speed Access to GLP-1 Drugs

UCSF research shows that international rules for biosimilars, mimics of biologic drugs like Ozempic and insulin, need to improve and match each another to encourage biosimilar development, testing, and approval. This would dramatically improve drug affordability just like generics has done.

Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?

About 6% of asymptomatic adults have a biomarker for Alzheimer's disease and are already showing very subtle signs of the disease that would not come to light in a standard cognitive test.

How New AI Cuts Breast Cancer Screening Time for High-Risk Women

Using AI on mammograms can identify patients at highest risk for breast cancer and get them same-day follow up care, eliminating stressful waiting times.

Improving Prediction of Alzheimer’s Disease with AI

A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and demographics.

Innovative Diabetes Researcher Joins National Academy of Sciences

Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.

Health Coaches Improve Outcomes for Patients with Asthma and COPD

Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with avoidable health care use.

How to Overcome Global Price Barriers for New Alzheimer’s Drugs

In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab (Leqembi) and donanemab (Kisulna) have been shown to slow progression of Alzheimer’s disease. However, the costs of these monoclonal antibodies are not affordable for many patients around the globe.

The Liver’s Immune Cells Might Be the Key to Curing Hepatitis B

Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.

Subscribe to